BioLife Solutions: Casdin Partners ups stake to 19.5% with $10.4M private placement

BIOLIFE SOLUTIONS INC

Sold 927,165 new shares to Casdin Partners at $11.19/share, raising ~$10.4M.
Casdin Partners' total ownership rises to ~19.5% of outstanding common stock post-placement.
Transaction closed immediately on October 19, 2023; registration statement to be filed within 30 days.
Issuance is below 20% threshold, so no shareholder vote required under Nasdaq listing rules.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

BIOLIFE SOLUTIONS INC entered into Securities Purchase Agreement with Casdin Partners Master Fund, L.P. valued at $10,374,976.35 (effective 2023-10-19).

Action: entry
Agreement: equity purchase
Counterparty: Casdin Partners Master Fund, L.P.
Value: $10,374,976.35
Effective: 2023-10-19

Exact text from the filing

On October 19, 2023, BioLife Solutions, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Casdin Partners Master Fund, L.P. (the “Purchaser”), whereby the Company will sell, and the Purchaser will purchase, 927,165 shares of common stock of the Company, par value $0.001 per share (the “Securities”), at a purchase price of $11.19 per share for an aggregate purchase price of $10,374,976.35

View on SEC.gov

Browse all material agreements →

BIOLIFE SOLUTIONS INC filing history →

Source: SEC EDGAR

accession 0001628280-23-034715

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.